Napabucasin, a STAT3 inhibitor, can inhibit the expression of stemness-associated genes and the growth of GBM spheroids in vitro [42], and has led to the loss of GSCs associated genes, induction of apoptosis, and inhibition of in vivo tumor growth of GSCs derived from recurrent GBM [43]. Here, STAT3 is linked to glioblastoma.